A detailed history of Compagnie Lombard Odier S Cm A transactions in Bio N Tech Se stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 4,240 shares of BNTX stock, worth $503,584. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,240
Previous 13,240 67.98%
Holding current value
$503,584
Previous $1.22 Million 72.15%
% of portfolio
0.01%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$80.36 - $102.87 $723,240 - $925,830
-9,000 Reduced 67.98%
4,240 $340,000
Q1 2024

May 01, 2024

SELL
$88.96 - $112.35 $1.4 Million - $1.77 Million
-15,780 Reduced 54.38%
13,240 $1.22 Million
Q4 2023

Jan 16, 2024

SELL
$90.91 - $112.75 $118,183 - $146,575
-1,300 Reduced 4.29%
29,020 $3.06 Million
Q3 2023

Oct 23, 2023

SELL
$98.5 - $125.08 $429,460 - $545,348
-4,360 Reduced 12.57%
30,320 $3.29 Million
Q2 2023

Aug 07, 2023

SELL
$102.58 - $129.66 $343,027 - $433,583
-3,344 Reduced 8.79%
34,680 $3.74 Million
Q1 2023

May 01, 2023

SELL
$122.57 - $153.67 $10,173 - $12,754
-83 Reduced 0.22%
38,024 $4.74 Million
Q4 2022

Feb 13, 2023

BUY
$118.43 - $186.05 $693,999 - $1.09 Million
5,860 Added 18.17%
38,107 $5.82 Million
Q3 2022

Nov 09, 2022

SELL
$127.65 - $183.11 $5.08 Million - $7.29 Million
-39,800 Reduced 55.24%
32,247 $4.39 Million
Q2 2022

Aug 11, 2022

BUY
$123.25 - $186.24 $184,875 - $279,360
1,500 Added 2.13%
72,047 $10.7 Million
Q1 2022

Apr 27, 2022

BUY
$126.25 - $231.85 $915,060 - $1.68 Million
7,248 Added 11.45%
70,547 $12 Million
Q4 2021

Feb 09, 2022

BUY
$216.64 - $362.52 $4.03 Million - $6.74 Million
18,600 Added 41.61%
63,299 $15.4 Million
Q3 2021

Oct 28, 2021

BUY
$205.93 - $447.23 $4.17 Million - $9.05 Million
20,234 Added 82.71%
44,699 $12.4 Million
Q2 2021

Jul 15, 2021

BUY
$113.32 - $241.49 $2.51 Million - $5.35 Million
22,155 Added 959.09%
24,465 $5.47 Million
Q1 2021

Apr 23, 2021

BUY
$85.73 - $119.5 $198,036 - $276,045
2,310 New
2,310 $250,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Compagnie Lombard Odier S Cm A Portfolio

Follow Compagnie Lombard Odier S Cm A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.